pink_usa_0231|WXXWY|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
pink_usa_0231|WXXWY|Long Name|WuXi Biologics (Cayman) Inc Total Current Assets (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Cash and Short Term Investments (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Inventories (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Net PP&E (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Goodwill and Intangibles (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Total Liabilities (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Total Current Liabilities (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Total Long Term Liabilities (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Total Deposits (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Book Value (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Retained Earnings (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Treasury Stock (Quarterly) (USD)|WuXi Biologics (Cayman) Inc EV to Revenues|WuXi Biologics (Cayman) Inc EV to Earnings|WuXi Biologics (Cayman) Inc EV to Free Cash Flow|WuXi Biologics (Cayman) Inc EV to Assets (Quarterly)|WuXi Biologics (Cayman) Inc PS Ratio|WuXi Biologics (Cayman) Inc PE Ratio|WuXi Biologics (Cayman) Inc Price to Book Value|WuXi Biologics (Cayman) Inc PEG Ratio|WuXi Biologics (Cayman) Inc Debt to Equity Ratio|WuXi Biologics (Cayman) Inc Dividend Yield|WuXi Biologics (Cayman) Inc Shareholder Yield (TTM)|WuXi Biologics (Cayman) Inc Percent of Shares Outstanding Short|WuXi Biologics (Cayman) Inc Total Receivables (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Total Payables (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Total Capital Stock (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Return on Invested Capital|WuXi Biologics (Cayman) Inc Quality Ratio Score|WuXi Biologics (Cayman) Inc Momentum Score|WuXi Biologics (Cayman) Inc Beta (1Y)|WuXi Biologics (Cayman) Inc Sustainable Growth Rate (TTM)|WuXi Biologics (Cayman) Inc Institutional Investor Ownership Percentage|WuXi Biologics (Cayman) Inc Average Diluted Shares Outstanding (Quarterly)|WuXi Biologics (Cayman) Inc Total Employees (Annual)|WuXi Biologics (Cayman) Inc EPS Diluted (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Dividend Per Share (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Revenue (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Gross Profit (Quarterly) (USD)|WuXi Biologics (Cayman) Inc SG&A Expense (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Pre-Tax Income (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Net Income (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Net Interest Income (Quarterly) (USD)|WuXi Biologics (Cayman) Inc Price (USD)|WuXi Biologics (Cayman) Inc Total Return Price (USD)|WuXi Biologics (Cayman) Inc Enterprise Value (USD)|WuXi Biologics (Cayman) Inc 30-Day Average Daily Volume|WuXi Biologics (Cayman) Inc 1 Year Price Returns (Daily)||
pink_usa_0231|WXXWY|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
pink_usa_0231|WXXWY|201612|119.4843|24.3476|11.3728|165.9781||246.8613|115.3044|131.5569||38.9424|||||||||||4.0242||||77.5048|62.5753|0.0227||||||||1624|||||||||||||||
pink_usa_0231|WXXWY|201706|639.7582|533.339|13.4952|190.6621||266.6515|127.4622|139.1893||564.2402|||||||||||0.3157||||85.5071|51.6539|0.0283|4.6357||||7.2093|||1998|||||||||||||||
pink_usa_0231|WXXWY|201712|464.6303|315.5305|20.7617|272.6689|0|126.3043|122.241|4.0633||616.4112|||34.3429|165.1753|-430.7975|8.3837|33.7869|273.9659|11.5432||0|0|-7.9614||123.0733|83.2215|0.0294|7.2754||||9.273|||2543|||||||||11.32|11.32|6227.7663|||11.46|11.46
pink_usa_0231|WXXWY|201803|||||||||||||48.9182||-229.8626||50.0515|317.4579|19.6551|||0||||||||||||||||||||||20.16|20.16|11421.682|1937.8||21.55|21.55
pink_usa_0231|WXXWY|201806|879.6166|659.5959|36.7121|326.8147|70.2021|159.8017|149.3872|10.4144||1134.4754|||55.5131|207.6343|-268.017|10.1771|53.8998|329.5857|21.4372||0|0|-3.2558||176.7708|87.1015|0.0303|7.6331||||8.2205|||3059|||||||||22.29|22.29|13317.5417|6688.8667||19.004|19.004
pink_usa_0231|WXXWY|201809|||||||||||||37.6479||-62.5075||42.0634|205.7189|10.9885|||0||||||||||||||||||||||20.36|20.36|11806.6223|5654.8667||19.89|19.89
pink_usa_0231|WXXWY|201812|835.178|593.7485|33.0265|422.1399|72.7484|203.3613|191.7077|11.6536||1162.0522|||22.0758|75.297|-36.3962|5.199|25.5916|130.8477|6.9893|0.3067|0|0|-5.8067||200.1488|116.2993|0.0294|9.7097|||2.3374|9.7099|||4141|||||||||12.95|12.95|7269.5557|4647.4667|11.5556|12.5|12.5
pink_usa_0231|WXXWY|201903|||||||||||||29.3293||-67.5472||33.1092|133.2795|10.0909|0.4695||0||||||||9|3.4896|||||||||||||19.21|19.21|11181.4874|2732.1333|-3.3702|20.068|20.068
pink_usa_0231|WXXWY|201906|726.6856|439.8856|46.3111|585.9873|46.7573|242.1492|195.8115|46.3377||1240.0892|||27.2945|87.2045|-60.96|7.1229|30.9284|124.501|9.4262|0.434|0|0|-0.0573||233.5978|127.7786|0.0296|10.2697||6|2.4595|10.2699|||4512|||||||||17.05|17.05|9857.4707|40604.1333|-17.7968|18.94|18.94
pink_usa_0231|WXXWY|201909|||||||||||||26.2914||-107.9766||29.2242|107.7433|9.8869|0.3166||0||||||||7|2.7047||1.0513|||||||||||20.1|20.1|12021.3001|5883.3333|-0.1968|19.88|19.88
pink_usa_0231|WXXWY|201912|1382.321|964.5085|57.0815|971.3532|85.9323|672.6151|410.3574|262.2577||1827.1667|||34.1558|107.6477|-137.1274|6.2473|37.6523|138.8157|12.7382|0.4945|0.1487|0|-3.6674||290.8783|219.2542|0.0306|9.6967||9|1.8423|10.3564|1.0834||5666|||||||||25.3275|25.3275|15716.7591|18997.8|101.8127|26.04|26.04
pink_usa_0231|WXXWY|202003|||||||||||||27.5761||-60.4055||29.5329|116.0215|9.0177|0.4941||0||||||||10|0.4837||0.8943|||||||||||25.31|25.31|15741.6329|18573.9|31.7543|29.45|29.45
pink_usa_0231|WXXWY|202006|1327.3652|758.1064|86.2719|1415.2906|83.3388|979.439|447.7336|531.7054||1922.7508|||38.5613|128.2748|-80.7623|8.0691|40.547|135.8361|12.4322|0.7919|0.2164|0|-2.727||400.6714|260.9206|0.0305|9.652||10|0.8478|11.0526|0.9511||5694|||||||||36.5035|36.5035|23582.2185|34341.6333|105.5377|36.29|36.29
pink_usa_0231|WXXWY|202009|||||||||||||52.8792||-56.4566||53.4558|179.0818|16.9861|1.0664||0||||||||10|1.0629||1.11|||||||||||48.125|48.125|32338.3617|46611.9|142.3817|52.65|52.65